Carole Huntsman, Chief Commercial Officer at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 2,234 shares at $314.74 ($727K) on 2025-03-03, disclosed to the SEC on 2025-03-05.
Scheduled sale ($727k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $313.08 | 71 | $22K | 3.1% |
| 2 | $314.74 | 200 | $63K | 8.7% |
| 3 | $320.21 | 300 | $96K | 13.2% |
| 4 | $323.65 | 200 | $65K | 8.9% |
| 5 | $323.65 | 200 | $65K | 8.9% |
| 6 | $324.59 | 200 |
| $65K |
| 8.9% |
| 7 | $324.59 | 200 | $65K | 8.9% |
| 8 | $326.34 | 100 | $33K | 4.5% |
| 9 | $327.49 | 100 | $33K | 4.5% |
| 10 | $329.64 | 100 | $33K | 4.5% |
| 11 | $335.00 | 563 | $189K | 25.9% |
| Total | $325.64 avg | 2,234 | $727K | 100% |
| Filing → |
| MDGL | SELL | 2025-11-21 | $1.8M | — | Filing → |
| MDGL | SELL | 2025-01-27 | $233K | — | Filing → |
| MDGL | SELL | 2024-11-22 | $436K | — | Filing → |